Core Viewpoint - Morgan Stanley increased its stake in Heng Rui Medicine (01276) by purchasing 1,386,751 shares at an average price of HKD 71.5162 per share, totaling approximately HKD 9,917.52 million, raising its total holdings to about 16,748,500 shares, which represents a 6.48% ownership stake [1] Summary by Category - Investment Activity - Morgan Stanley's recent purchase of 1,386,751 shares indicates a strategic move to bolster its investment in Heng Rui Medicine [1] - The average purchase price of HKD 71.5162 per share reflects the firm's confidence in the company's future performance [1] - Ownership Structure - Following the acquisition, Morgan Stanley's total shareholding in Heng Rui Medicine increased to approximately 16,748,500 shares [1] - The updated ownership percentage of 6.48% signifies a notable presence in the company's shareholder base [1]